Clinical Trials on 可切除的 MMR 缺陷实体瘤 in United Kingdom
总计3337个结果
-
Albert Einstein College of Medicine终止
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany主动,不招人
-
National Cancer Institute (NCI)招聘中
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany终止
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany终止
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany招聘中
-
SCRI Development Innovations, LLCNovartis Pharmaceuticals完全的Metastatic or Unresectable Solid Tumor Malignancy美国
-
Syndax Pharmaceuticals完全的
-
Ikena Oncology招聘中实体瘤 | 实体瘤,成人 | 恶性胸膜间皮瘤 (MPM) | 上皮样血管内皮瘤 (EHE) | NF2缺陷型间皮瘤 | 其他 NF2 缺陷实体瘤和具有 YAP1/TAZ 融合基因的实体瘤 | NF2 缺陷 | YAP1 或 TAZ 基因融合美国, 英国
-
Frontier Medicines Corporation招聘中大肠癌 | 胰腺癌 | 非小细胞肺癌 | 转移性实体瘤 | 实体瘤,成人 | 不可切除的实体瘤 | 克拉斯G12C | 具有 KRAS G12C 突变的晚期实体瘤美国
-
Massachusetts General HospitalBoehringer Ingelheim; Incyte Corporation招聘中
-
AstraZeneca完全的Advanced Solid Metastatic Tumor英国
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Shanghai Xianxiang Medical Technology Co., Ltd.; Simcere Zaiming招聘中
-
Immatics US, Inc.完全的
-
Blueprint Medicines Corporation完全的
-
CytomX Therapeutics终止
-
Novartis Pharmaceuticals招聘中
-
ArQule, Inc. (a wholly owned subsidiary of Merck...完全的
-
National Cancer Institute (NCI)完全的晚期恶性实体瘤 | 难治性恶性实体瘤 | 复发性恶性实体瘤 | 转移性恶性实体瘤 | 卵巢癌 | 胰腺神经内分泌肿瘤 | 不可切除的实体瘤 | 纤维板层癌美国
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; Onyx Therapeutics, Inc.完全的
-
Georgetown UniversityImmune System Key Ltd招聘中
-
Memorial Sloan Kettering Cancer CenterAstraZeneca招聘中
-
Queen Mary University of London招聘中
-
Nerviano Medical Sciences终止
-
University College, LondonImperial College London; Cancer Research UK; National Cancer Imaging Translational Accelerator招聘中
-
Incyte Corporation招聘中
-
AstraZeneca招聘中MTAP 缺陷的晚期实体瘤美国, 西班牙, 大韩民国, 澳大利亚, 日本, 中国, 荷兰, 法国